Press Releases

Adamas Reports Recent Achievements and Second Quarter 2017 Financial Results
Aug 8, 2017

Adamas to Announce Second Quarter 2017 Financial Results and Host Conference Call on August 8, 2017
Aug 1, 2017

Adamas Reports Inducement Grant to New Chief Financial Officer
Jul 10, 2017

Adamas Appoints New Chief Financial Officer
Jun 28, 2017

Adamas Announces Publication of ADS-5102 Phase 3 EASE LID Clinical Trial in JAMA Neurology
Jun 12, 2017

Adamas Presents Expanded Analysis from the ADS-5102 Open-Label Study Showing Tolerability and Durability out to 88 Weeks
Jun 8, 2017

Adamas to Present at Two Upcoming Investor Conferences
Jun 1, 2017

Adamas Presents Positive Phase 1a Data of ADS-4101 (lacosamide) for the Treatment of Partial Onset Seizures in Epilepsy
May 22, 2017

Adamas Signs $100 Million Royalty-Backed Note Agreement with HealthCare Royalty Partners
May 11, 2017

Adamas Reports Inducement Grant to New Chief Operating Officer
May 5, 2017